Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN - Kinlough-Rathbone, RL; Perry, DW; Rand, ML; Packham, MA (Thromb Haemost, 1997)